News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.


Ramp Network rolls out multichain wallet for simpler self-custody
Cointelegraph·2026/04/17 13:03
Dovish Shift? Interest Rate Swap Market Pricing in 15 bps Fed Rate Cut by December
BlockBeats·2026/04/17 12:59
Elon Musk Fuels ASTEROID Crypto Frenzy, Scores 500X Windfall For One Trader
BeInCrypto·2026/04/17 12:54

Crypto Capital Shifts to Stablecoins as Risk Appetite Falls, Market Cap Tops $320B
CoinEdition·2026/04/17 12:51

Pundit Says This Chart Paints The Clearest Macro Picture For XRP
Newsbtc·2026/04/17 12:51
USD/CHF Price Forecast: Bearish Flag formation warrants more downside below 0.7790
101 finance·2026/04/17 12:39
Critical Metals stock surges after taking full control of Greenland rare earth project
Mining.com·2026/04/17 12:36
Canada's cross-border securities dealings, February 2026
101 finance·2026/04/17 12:33
Goldman Sachs Files for Unique Bitcoin ETF Offering Yield to Investors
Dailyhodl·2026/04/17 12:27

Woman-Founded and Led Solana Project Kokopi Koalas Launches KOKOP Token and NFT Project
Dailyhodl·2026/04/17 12:27
Flash
20:30
According to the latest public documents from the U.S. Securities and Exchange Commission (SEC), the French regulatory authority officially approved the foreign direct investment (FDI) permit for the merger between Biomarin Pharmaceutical Inc and Amicus Therapeutics on April 23, 2026.The acquisition of this key regulatory approval marks the removal of a major regulatory hurdle for this highly-watched biopharmaceutical industry merger. Both companies possess leading technology platforms and product pipelines in the field of rare disease treatment, and this integration will create significant synergies. Foreign investment review in cross-border mergers and acquisitions is a crucial step to ensure that the deal aligns with national security and economic interests in each country. The clearance by the French authorities lays a solid foundation for the subsequent approvals in other jurisdictions required to complete the transaction.
20:28
Franklin Street Properties Corp (FSP) recently disclosed that the company is continuing to conduct an in-depth evaluation of multiple strategic alternatives.These options cover a wide range of possibilities, including but not limited to an overall sale of the company, seeking merger and acquisition opportunities, divesting certain assets, exploring joint venture collaborations, and engaging in transactions to optimize the capital structure. This move indicates that the real estate investment trust is actively considering various paths to potentially enhance shareholder value and optimize its business layout. The company’s management emphasized that it is still in the evaluation phase and no final decisions have been made regarding any specific transactions. The assessment process will comprehensively consider multiple factors such as the market environment, the company’s financial condition, and its long-term development strategy. Industry analysts believe that FSP's actions may reflect its intention to seek business transformation or maximize value under the current commercial real estate market environment. The company stated that it will provide timely updates to the market based on the progress of the evaluation.
20:28
Special Purpose Acquisition Company ESH Acquisition Corp recently disclosed that it has officially received a compliance deficiency notice from the Nasdaq Stock Exchange.The notice indicates that the company currently fails to meet the requirements related to continued listing standards. In response to this situation, the board of directors has decided to initiate a public share redemption procedure, under which cash redemptions of publicly issued common shares will be made as prescribed in the charter. Following the completion of the share redemption, ESH Acquisition Corp will enter the voluntary dissolution and liquidation stage, and plans to submit dissolution application documents to the relevant regulatory authorities. This action marks the SPAC platform’s official entry into the termination of operations process after failing to complete its acquisition target. The company stated it will properly handle subsequent liquidation and investor compensation matters in accordance with securities regulations.